| abstract |
(57) [Summary] (Modified) [PROBLEMS] Diseases or pathological conditions related to extracellular matrix degeneration (for example, degeneration diseases, especially atherosclerosis, cancer, infection or other inflammatory diseases) Prophylaxis and treatment-substances and-formulations. A pharmaceutical composition comprising ascorbic acids, at least one fibrinolysis inhibitor and a pharmaceutically acceptable carrier, wherein the ascorbic acids and fibrinolysis collagenase inhibitor is a collagenase-related degenerative disease. The above-described composition, which contains the composition in an amount sufficient to treat the above. |